ASB17
gene geneOn this page
Summary
ASB17 (ankyrin repeat and SOCS box containing 17, HGNC:19769) is a protein-coding gene on chromosome 1p31.1, encoding Ankyrin repeat and SOCS box protein 17 (Q8WXJ9). May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
Predicted to be involved in intracellular signal transduction and protein ubiquitination. Predicted to be located in cytosol.
Source: NCBI Gene 127247 — RefSeq curated summary.
At a glance
- Gene–disease (curated): congenital heart defects, multiple types (Limited, GenCC)
- GWAS associations: 7
- Clinical variants (ClinVar): 35 total
- MANE Select transcript:
NM_080868
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19769 |
| Approved symbol | ASB17 |
| Name | ankyrin repeat and SOCS box containing 17 |
| Location | 1p31.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000154007 |
| Ensembl biotype | protein_coding |
| OMIM | 619936 |
| Entrez | 127247 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000284142
RefSeq mRNA: 1 — MANE Select: NM_080868
NM_080868
CCDS: CCDS671
Canonical transcript exons
ENST00000284142 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001013510 | 75922080 | 75922359 |
| ENSE00001067049 | 75931891 | 75932404 |
| ENSE00001453696 | 75918873 | 75919158 |
Expression profiles
Bgee: expression breadth broad, 24 present calls, max score 97.78.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0310 / max 27.8095, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 12878 | 0.0310 | 3 |
Top tissues by expression
222 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 97.78 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 93.86 | gold quality |
| adult organism | UBERON:0007023 | 91.82 | gold quality |
| left testis | UBERON:0004533 | 90.41 | gold quality |
| right testis | UBERON:0004534 | 90.01 | gold quality |
| testis | UBERON:0000473 | 88.14 | gold quality |
| tibialis anterior | UBERON:0001385 | 67.83 | silver quality |
| deltoid | UBERON:0001476 | 56.38 | gold quality |
| ileal mucosa | UBERON:0000331 | 55.64 | silver quality |
| pancreatic ductal cell | CL:0002079 | 54.76 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 54.01 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| quadriceps femoris | UBERON:0001377 | 47.51 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| vastus lateralis | UBERON:0001379 | 45.40 | gold quality |
| cauda epididymis | UBERON:0004360 | 44.24 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 42.19 | gold quality |
| muscle tissue | UBERON:0002385 | 42.09 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.77 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.47 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- expressed exclusively in testis (PMID:15204681)
- ASB17 Facilitates the Burst of LPS-Induced Inflammation Through Maintaining TRAF6 Stability. (PMID:35174103)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Asb17 | ENSMUSG00000038997 |
| rattus_norvegicus | Asb17 | ENSRNOG00000048832 |
| drosophila_melanogaster | stops | FBGN0086704 |
Protein
Protein identifiers
Ankyrin repeat and SOCS box protein 17 — Q8WXJ9 (reviewed: Q8WXJ9)
All UniProt accessions (1): Q8WXJ9
UniProt curated annotations — full annotation on UniProt →
Function. May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
Tissue specificity. Specifically expressed in testis. Not detected in other tissues tested.
Domain organisation. The SOCS box domain mediates the interaction with the Elongin BC complex, an adapter module in different E3 ubiquitin-protein ligase complexes.
Pathway. Protein modification; protein ubiquitination.
Similarity. Belongs to the ankyrin SOCS box (ASB) family.
RefSeq proteins (1): NP_543144* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001496 | SOCS_box | Domain |
| IPR036036 | SOCS_box-like_dom_sf | Homologous_superfamily |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
| IPR039147 | ASB17 | Family |
Pfam: PF07525
UniProt features (5 total): sequence variant 2, chain 1, repeat 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WXJ9-F1 | 86.18 | 0.64 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-8951664 | Neddylation |
| R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation |
| R-HSA-1280218 | Adaptive Immune System |
| R-HSA-168256 | Immune System |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-597592 | Post-translational protein modification |
| R-HSA-983169 | Class I MHC mediated antigen processing & presentation |
MSigDB gene sets: 37 (showing top):
REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION, REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION, YGACNNYACAR_UNKNOWN, WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN, TGACATY_UNKNOWN, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_PROTEIN_POLYUBIQUITINATION, ATF3_Q6, GOCC_CELL_CELL_JUNCTION, GOCC_ANCHORING_JUNCTION, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP, REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, REACTOME_NEDDYLATION, GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN
GO Biological Process (5): protein polyubiquitination (GO:0000209), intracellular signal transduction (GO:0035556), cell-cell junction disassembly (GO:0150147), spermatid cytoplasm removal during spermiation of flagellated sperm (GO:0160087), protein ubiquitination (GO:0016567)
GO Molecular Function (0):
GO Cellular Component (2): cytosol (GO:0005829), apical ectoplasmic specialization (GO:0061831)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
| Class I MHC mediated antigen processing & presentation | 1 |
| Immune System | 1 |
| Metabolism of proteins | 1 |
| Adaptive Immune System | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein ubiquitination | 1 |
| intracellular anatomical structure | 1 |
| signal transduction | 1 |
| cell-cell junction organization | 1 |
| cell junction disassembly | 1 |
| developmental process involved in reproduction | 1 |
| spermatogenesis | 1 |
| protein modification by small protein conjugation | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| cell-cell junction | 1 |
Protein interactions and networks
STRING
370 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ASB17 | ASB2 | Q96Q27 | 864 |
| ASB17 | TGM6 | O95932 | 771 |
| ASB17 | ADAM8 | P78325 | 724 |
| ASB17 | OR5M11 | Q96RB7 | 606 |
| ASB17 | CCDC190 | Q86UF4 | 597 |
| ASB17 | ASB11 | Q8WXH4 | 568 |
| ASB17 | OR5AR1 | Q8NGP9 | 538 |
| ASB17 | TAS2R1 | Q9NYW7 | 530 |
| ASB17 | SRFBP1 | Q8NEF9 | 508 |
| ASB17 | CCDC126 | Q96EE4 | 507 |
| ASB17 | CLEC12B | Q2HXU8 | 506 |
| ASB17 | OR5M10 | Q6IEU7 | 501 |
| ASB17 | ASB18 | Q6ZVZ8 | 497 |
| ASB17 | ASB1 | Q9Y576 | 492 |
| ASB17 | OR2I1 | Q8NGU4 | 482 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ASB17 | HSP90AB1 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (26): ASB17 (PCA), ASB17 (Negative Genetic), BIK (Affinity Capture-Western), ASB17 (Affinity Capture-Western), TRAF6 (Affinity Capture-Western), ASB17 (Affinity Capture-Western), ASB17 (Affinity Capture-Luminescence), HSPB1 (Affinity Capture-MS), TCEB2 (Affinity Capture-MS), RCN2 (Affinity Capture-MS), TUFM (Affinity Capture-MS), ATP2A2 (Affinity Capture-MS), SSR4 (Affinity Capture-MS), ARF4 (Affinity Capture-MS), VAPA (Affinity Capture-MS)
ESM2 similar proteins: A0A2B4RNI3, A0A3M6TIF0, A0A8B8EY61, A0A913XCT1, A8DYP7, G5EBL2, G5ED39, O14061, O17657, O36386, P0DXM7, P0DXM8, P17595, P24447, P30024, P32742, P52344, P52448, P52527, P89680, P89884, P90245, Q01013, Q01015, Q05930, Q09346, Q10122, Q10128, Q13535, Q18008, Q18262, Q18LC9, Q18LD0, Q20849, Q23652, Q32KY8, Q66640, Q69555, Q6UDH7, Q7KLI1
Diamond homologs: Q32KY8, Q8HYV8, Q8VHP9, Q8WXJ9, Q95LR4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 34 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
434 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:75931892:T:TA | donor_gain | 0.9600 |
| 1:75928857:CAA:C | acceptor_gain | 0.9500 |
| 1:75919159:C:CC | acceptor_gain | 0.9300 |
| 1:75919157:GTCT:G | acceptor_gain | 0.9100 |
| 1:75932337:A:AC | donor_gain | 0.9000 |
| 1:75932338:C:CC | donor_gain | 0.9000 |
| 1:75919155:GTGTC:G | acceptor_gain | 0.8900 |
| 1:75919156:TGTCT:T | acceptor_gain | 0.8900 |
| 1:75922360:C:CC | acceptor_gain | 0.8800 |
| 1:75931885:TATTA:T | donor_loss | 0.8700 |
| 1:75931886:ATTAC:A | donor_loss | 0.8700 |
| 1:75931887:TTA:T | donor_loss | 0.8700 |
| 1:75931888:TACCT:T | donor_loss | 0.8700 |
| 1:75931889:AC:A | donor_loss | 0.8700 |
| 1:75931890:CCTCC:C | donor_loss | 0.8700 |
| 1:75932044:A:AC | donor_gain | 0.8600 |
| 1:75932045:C:CC | donor_gain | 0.8600 |
| 1:75931891:C:G | donor_loss | 0.8500 |
| 1:75919158:TCT:T | acceptor_gain | 0.7900 |
| 1:75928858:A:T | acceptor_gain | 0.7900 |
| 1:75919155:GTGT:G | acceptor_gain | 0.7600 |
| 1:75919157:GTCTG:G | acceptor_loss | 0.7600 |
| 1:75919158:TC:T | acceptor_loss | 0.7600 |
| 1:75919159:C:G | acceptor_loss | 0.7600 |
| 1:75919160:T:A | acceptor_loss | 0.7600 |
| 1:75919170:C:CT | acceptor_loss | 0.7500 |
| 1:75919171:A:T | acceptor_loss | 0.7500 |
| 1:75919161:G:C | acceptor_loss | 0.7400 |
| 1:75931889:ACCT:A | donor_gain | 0.7300 |
| 1:75931890:CCTC:C | donor_gain | 0.7300 |
AlphaMissense
1918 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:75919045:C:A | R265S | 0.997 |
| 1:75919045:C:G | R265S | 0.997 |
| 1:75922297:G:T | A155D | 0.997 |
| 1:75919046:C:A | R265M | 0.995 |
| 1:75919037:A:G | L268P | 0.994 |
| 1:75919046:C:G | R265T | 0.994 |
| 1:75922252:C:A | G170V | 0.994 |
| 1:75922353:G:C | F136L | 0.994 |
| 1:75922353:G:T | F136L | 0.994 |
| 1:75922355:A:G | F136L | 0.994 |
| 1:75931948:A:G | L115P | 0.994 |
| 1:75931986:A:C | F102L | 0.994 |
| 1:75931986:A:T | F102L | 0.994 |
| 1:75931988:A:G | F102L | 0.994 |
| 1:75922121:A:G | C214R | 0.993 |
| 1:75931994:A:G | W100R | 0.993 |
| 1:75931994:A:T | W100R | 0.993 |
| 1:75918968:A:G | L291P | 0.992 |
| 1:75922252:C:T | G170E | 0.992 |
| 1:75922312:G:C | P150R | 0.992 |
| 1:75922312:G:T | P150H | 0.992 |
| 1:75931895:A:G | W133R | 0.992 |
| 1:75931895:A:T | W133R | 0.992 |
| 1:75922261:A:G | L167P | 0.991 |
| 1:75931980:T:A | R104S | 0.991 |
| 1:75931980:T:G | R104S | 0.991 |
| 1:75932015:A:G | C93R | 0.991 |
| 1:75919119:A:G | W241R | 0.990 |
| 1:75919119:A:T | W241R | 0.990 |
| 1:75931951:A:G | L114P | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000179627 (1:75933301 C>G,T), RS1000198562 (1:75924100 A>G), RS1000432580 (1:75931615 CTTTG>C), RS1000675943 (1:75923735 G>A), RS1001214180 (1:75923489 G>A), RS1001223280 (1:75934171 T>A), RS1002455058 (1:75928970 G>C,T), RS1002488932 (1:75928986 G>A), RS1002594966 (1:75918922 T>C), RS1002710018 (1:75921021 G>A,C,T), RS1002796022 (1:75925569 A>T), RS1002842999 (1:75926916 G>A), RS1002847831 (1:75932994 C>T), RS1003154594 (1:75925917 G>A), RS1003192512 (1:75927216 A>G)
Disease associations
OMIM: gene MIM:619936 | disease phenotypes:
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| congenital heart defects, multiple types | Limited | Autosomal dominant |
Mondo (1): congenital heart defects, multiple types (MONDO:0000119)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003025_6 | Attention function in attention deficit hyperactive disorder | 9.000000e-07 |
| GCST003518_98 | Daytime sleep phenotypes | 3.000000e-06 |
| GCST006249_16 | Serum metabolite levels | 1.000000e-24 |
| GCST006249_6 | Serum metabolite levels | 6.000000e-30 |
| GCST006249_72 | Serum metabolite levels | 1.000000e-18 |
| GCST006249_82 | Serum metabolite levels | 4.000000e-15 |
| GCST009391_827 | Metabolite levels | 3.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007636 | attention function measurement |
| EFO:0007828 | daytime rest measurement |
| EFO:0006523 | symmetrical dimethylarginine measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: congenital heart defects, multiple types
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): congenital heart defects, multiple types